Guardant360’s Comprehensive Genotyping in NSCLC
Home » Guardant360’s Comprehensive Genotyping in NSCLC

GH AMEA on Social Media Guardant360’s Comprehensive Genotyping in NSCLC
Guardant360’s Comprehensive Genotyping in NSCLC
Guardant360’s Comprehensive Genotyping in NSCLC
GH AMEA

The Guardant360® test provided comprehensive genomic profiling information for a patient with stage four lung cancer. The resulting treatment decisions saw a positive response from the patient. Click on the video to find out more.

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.

Open chat
Message us